| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Avicena is a private company backed by the Australian government. Our mission is to develop low-cost ultra-high-throughput molecular diagnostic and screening instruments to detect SARS-CoV-2 and other pathogens. Learning from the experience of the global pandemic our platform is designed for pandemic-scale throughput, being able to screen up to 92,160 individuals eith saliva samles every 24 hours. Major near-term applications include large-scale sentinel testing of entire suburbs, regions, and cities; high-density environments such as airports and cruise ships; and crowded places such as factories complexes, major public events, and religious festivals. |
| Category: | Health & biotech |
| URL: | https://avicenasystems.com |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2020 |
| Address: | 30 Coolgardie St, West Perth, WA 6005 |
| State: | Western Australia |
| Overseas Operations: | No |
| Twitter: | [twitter-timeline username=”“] |
| Facebook: | |
| Linkedin: | https://www.linkedin.com/company/avicena-systems/ |
| Founders: | |
| Awards won: | |

